See more : PacWest Equities Inc. (PWEI) Income Statement Analysis – Financial Results
Complete financial analysis of Molecular Data Inc. (MKD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Molecular Data Inc., a leading company in the Chemicals industry within the Basic Materials sector.
- Torishima Pump Mfg. Co., Ltd. (6363.T) Income Statement Analysis – Financial Results
- Apple Inc. (APC.DE) Income Statement Analysis – Financial Results
- Zuari Industries Limited (ZUARIGLOB.NS) Income Statement Analysis – Financial Results
- Big Lots, Inc. (BIGGQ) Income Statement Analysis – Financial Results
- Mitsubishi Corporation (MTSUY) Income Statement Analysis – Financial Results
Molecular Data Inc. (MKD)
About Molecular Data Inc.
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. Molecular Data Inc. was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Revenue | 7.60B | 13.21B | 9.05B | 4.20B | 3.21B |
| Cost of Revenue | 7.61B | 13.11B | 8.97B | 4.15B | 3.18B |
| Gross Profit | -10.20M | 100.77M | 80.17M | 50.23M | 26.12M |
| Gross Profit Ratio | -0.13% | 0.76% | 0.89% | 1.20% | 0.81% |
| Research & Development | 35.22M | 45.04M | 36.89M | 18.61M | 20.07M |
| General & Administrative | 210.40M | 104.47M | 173.87M | 41.72M | 41.80M |
| Selling & Marketing | 67.02M | 108.86M | 103.29M | 64.96M | 59.16M |
| SG&A | 277.42M | 213.33M | 277.17M | 106.68M | 100.96M |
| Other Expenses | 8.72M | 34.62M | 1.91M | 14.68M | 10.86M |
| Operating Expenses | 321.36M | 292.99M | 315.96M | 139.97M | 131.89M |
| Cost & Expenses | 7.93B | 13.40B | 9.29B | 4.29B | 3.31B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 10.73M | 4.37M | 19.05M | 16.83M | 8.44M |
| Depreciation & Amortization | 1.72M | 3.05M | 2.44M | 1.49M | 978.00K |
| EBITDA | -188.80M | 60.12M | -233.15M | -89.49M | -104.52M |
| EBITDA Ratio | -4.12% | -1.41% | -2.58% | -2.13% | -3.26% |
| Operating Income | -331.56M | -192.21M | -235.79M | -91.18M | -105.77M |
| Operating Income Ratio | -4.36% | -1.46% | -2.60% | -2.17% | -3.30% |
| Total Other Income/Expenses | -136.78M | -871.00K | -18.85M | -16.63M | -8.16M |
| Income Before Tax | -325.58M | -193.08M | -254.64M | -107.81M | -113.94M |
| Income Before Tax Ratio | -4.29% | -1.46% | -2.81% | -2.57% | -3.55% |
| Income Tax Expense | 2.46M | 465.00K | 202.00K | 202.00K | 273.00K |
| Net Income | -328.04M | -193.55M | -254.64M | -107.81M | -113.94M |
| Net Income Ratio | -4.32% | -1.47% | -2.81% | -2.57% | -3.55% |
| EPS | -2.62 | -1.87 | -2.21 | -0.94 | -0.99 |
| EPS Diluted | -2.62 | -1.87 | -2.21 | -0.94 | -0.99 |
| Weighted Avg Shares Out | 125.35M | 103.54M | 115.04M | 115.04M | 115.04M |
| Weighted Avg Shares Out (Dil) | 125.35M | 103.54M | 115.04M | 115.04M | 115.04M |
Penny Stocks To Buy Now? 6 To Watch Under $1 This Week
Penny Stocks To Buy Now? 4 To Watch Under $1 This Week
Hot Nasdaq & NYSE Penny Stocks To Buy For Under $1 Right Now
Best Penny Stocks To Buy? 5 Explosive Stocks Under $1 To Watch Now
Top Penny Stocks Today: Why MKD, AEI and MULN Are Up Monday
5 Penny Stocks Under $1 To Buy According To Redditors This Week
Hot Penny Stocks Under $1 To Watch Before Next Week
Best Penny Stocks Under $1 To Watch As Bitcoin Cracks $58,000
Seres Therapeutics Molecular Data On SER-109 Looks Good
Top Penny Stocks Today: Why MKD, FAMI, METX, GROM, CEI and BLIN Are on the Move Thursday
Source: https://incomestatements.info
Category: Stock Reports